Successful use of an anti-CD20 antibody (rituximab) for the treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease
BONE MARROW TRANSPLANTATION(2001)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要